Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
Citations    
"SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia"
written by Fatih M. Uckun, Sanjive Qazi,
published by Journal of Cancer Therapy, Vol.5 No.1, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
European Journal of …, 2024
[2] Macrocyclization Strategy for Improving Candidate Profiles in Medicinal Chemistry
European Journal of …, 2024
[3] Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors
Bioorganic & Medicinal …, 2023
[4] Blue Light Inhibits Proliferation of Metastatic Cancer Cells by Regulating Translational Initiation: A Synergistic Property with Anticancer Drugs
Photochemistry and …, 2023
[5] In silico methods for modeling of genomic regions for immunological and metabolic gene modulating to stress response in chicken: where we are?
2022
[6] Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy
Drugs of the …, 2022
[7] Untersuchung der Rolle von BRD7 und DOT1L im Prä-B-Zellrezeptor-Signalweg
2022
[8] Candida Administration Worsens Neutrophil Extracellular Traps in Renal Ischemia Reperfusion Injury Mice: An Impact of Gut Fungi on Acute Kidney Injury
Journal of Innate …, 2022
[9] Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance
Cancer Drug Resistance, 2022
[10] Wilasinee Saisorn 1, 2, Supichcha Saithong 3, Pornpimol Phuengmaung2, 3, Kanyarat Udompornpitak 3, Thansita Bhunyakarnjanarat 3, Peerapat Visitchanakun 3
Innate Immunity in Kidney Injury …, 2022
[11] End User Licence Agreement
Changes, 2021
[12] Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With …
2021
[13] Nanocarriers as Magic Bullets in the Treatment of Leukemia
2020
[14] Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase
2020
[15] Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors
2020
[16] Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
2020
[17] NCI Alliance for Nanotechnology in Cancer–Catalysing Research and Translation Towards Novel Cancer Diagnostics and Therapeutics
2019
[18] National Cancer Institute Alliance for nanotechnology in cancer—Catalyzing research and translation toward novel cancer diagnostics and therapeutics
2019
[19] Ki‐67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1‐mutant and 1p/19q‐codeleted: a multicenter study from …
2019
[20] Role of Syk gene promoter demethylation in the biological behavior of medulloblastoma
2019
[21] Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays
Oncotarget, 2018
[22] Spleen tyrosine kinase (SYK) protects renal tubular epithelial cell against hypoxia injury in children with acute kidney injury
Gene, 2018
[23] Role of Protein Kinases and Their Inhibitors in Radiation Response of Tumor Cells
Current Pharmaceutical Design, 2017
[24] Syk inhibitors in clinical development for hematological malignancies
2017
[25] An in vivo RNAi therapy screen identifies novel mediators of leukemia-microenvironment interaction
2017
[26] Вплив інгібітора протеїнкіназ похідного малеіміду на морфофункціональний стан мишачих лейкемічних клітин L1210
В?сник Льв?вського ун?верситету. Сер?я б?олог?чна , 2016
[27] Therapeutic Approaches to Drug Targets in Leukemia
Int J Ayu Pharm Chem, 2016
[28] Recent advances and novel treatment paradigms in acute lymphocytic leukemia
2016
[29] Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3
Oncotarget, 2016
[30] Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.
Oncotarget, 2016
[31] Lipid Phosphatases and Oxidative Signalling in T Lymphocytes
2015
[32] A Woman With CD19-Positive, B-Cell ALL
2015
[33] Response to tyrosine kinase inhibitors in a transplantable mouse model of BCR-ABL1+ BCP-ALL
2015
[34] Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
Journal of cellular and molecular medicine, 2015
[35] 21: Leveraging Structure-Based Rational Drug Design and Nanotechnology to Destroy Leukemic Stem Cells
Stem Cells, 2015
[36] Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia
Haematologica, 2015
[37] The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
Leukemia, 2015
[38] Somatic copy number losses on chromosome 9q21. 33q22. 33 encompassing the PTCH1 loci associated with cardiac fibroma
Cancer genetics, 2015
[39] Appendix: Response to tyrosine kinase inhibitors in a transplantable mouse model of BCR-ABL1+ BCP-ALL
Signature redacted, 2015
[40] Precursor B-cell acute lymphoblastic leukemia and the problem ofminimal residual disease
2015
[41] Lipid Phosphatases and Oxidative Signalling in T Lymphocyte Biology
2015
[42] Somatic copy number losses on chromosome 9q21.33q22.33 encompassing the PTCH1 loci associated with cardiac fibroma
Cancer Genetics, 2015
[43] Leveraging Structure-Based Rational Drug Design and Nanotechnology to Destroy Leukemic Stem Cells
Stem Cells, Tissue Engineering and Regenerative Medicine, 2014
Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top